Painful neuropathies: The emerging role of sodium channelopathies

Journal of the Peripheral Nervous System

Volumn 19, Issue 2, 2014, Pages 53-65

  Brouwer, Brigitte A ^a   Merkies, Ingemar S J ^a,b   Gerrits, Monique M ^a   Waxman, Stephen G ^c,d   Hoeijmakers, Janneke G J ^a   Faber, Catharina G ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Channelopathies; Neuropathy; Pain; Sodium channels

Indexed keywords

SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.3; SODIUM CHANNEL NAV1.4; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.6; SODIUM CHANNEL NAV1.7; SODIUM CHANNEL NAV1.8; SODIUM CHANNEL NAV1.9; VOLTAGE GATED SODIUM CHANNEL; SODIUM CHANNEL;

ACROMESOMELIA; AUTONOMIC DYSFUNCTION; CHANNEL GATING; CONFERENCE PAPER; DYSAUTONOMIA; FIBROMYALGIA; FOOT MALFORMATION; GAIN OF FUNCTION MUTATION; HAND MALFORMATION; HUMAN; LOSS OF FUNCTION MUTATION; MEMBRANE ELECTROPHYSIOLOGY; MEMBRANE STEADY POTENTIAL; NERVE FIBER DEGENERATION; OSTEOARTHRITIS; PAIN; PERIPHERAL NEUROPATHY; PHANTOM PAIN; PRIORITY JOURNAL; SCIATICA; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FIBER NEUROPATHY; SODIUM CHANNELOPATHY; STEADY STATE; CHANNELOPATHY; GENETICS; MUTATION; PATHOPHYSIOLOGY;

CHANNELOPATHIES; HUMANS; MUTATION; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; SODIUM CHANNELS;

EID: 84918525451     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/jns5.12071     Document Type: Conference Paper

References (109)

1. Abrahamsen B, Zhao J, Asante CO, Cendan CM, Marsh S, Martinez-Barbera JP, Nassar MA, Dickenson AH, Wood JN (2008). The cell and molecular basis of mechanical, cold, and inflammatory pain. Science 321:702-705.
2. Akopian AN, Sivilotti L, Wood JN (1996). A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379:257-262.
3. Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon SB, Boyce S, Hill R, Stanfa LC, Dickenson AH, Wood JN (1999). The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 2:541-548.
4. Alharby SW (2010). Anterior cruciate ligament injuries in growing skeleton. Int J Health Sci (Qassim) 4:71-79.
5. Argyriou AA, Cavaletti G, Antonacopoulou A, Genazzani AA, Briani C, Bruna J, Terrazzino S, Velasco R, Alberti P, Campagnolo M, Lonardi S, Cortinovis D, Cazzaniga M, Santos C, Psaromyalou A, Angelopoulou A, Kalofonos HP (2013). Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study. Cancer 119:3570-3577.
6. Attal N, Lanteri-Minet M, Laurent B, Fermanian J, Bouhassira D (2011). The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 152:2836-2843.
7. Baker MD, Chandra SY, Ding Y, Waxman SG, Wood JN (2003). GTP-induced tetrodotoxin-resistant Na+ current regulates excitability in mouse and rat small diameter sensory neurones. J Physiol 548:373-382.
8. Bakkers M, Merkies IS, Lauria G, Devigili G, Penza P, Lombardi R, Hermans MC, van Nes SI, De Baets M, Faber CG (2009). Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 73:1142-1148.
9. Bakkers M, Faber CG, Hoeijmakers JG, Lauria G, Merkies IS (2014). Small fibers, large impact: quality of life in small-fiber neuropathy. Muscle Nerve 49:329-336.
10. Beckers MC, Ernst E, Belcher S, Howe J, Levenson R, Gros P (1996). A new sodium channel alpha-subunit gene (Scn9a) from Schwann cells maps to the Scn1a, Scn2a, Scn3a cluster of mouse chromosome 2. Genomics 36:202-205.
11. Bednarik J, Vlckova-Moravcova E, Bursova S, Belobradkova J, Dusek L, Sommer C (2009). Etiology of small-fiber neuropathy. J Peripher Nerv Syst 14:177-183.
12. Black JA, Westenbroek RE, Catterall WA, Waxman SG (1995). Type II brain sodium channel expression in non-neuronal cells: embryonic rat osteoblasts. Brain Res Mol Brain Res 34:89-98.
13. Black JA, Cummins TR, Plumpton C, Chen YH, Hormuzdiar W, Clare JJ, Waxman SG (1999). Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J Neurophysiol 82:2776-2785.
14. Black JA, Nikolajsen L, Kroner K, Jensen TS, Waxman SG (2008). Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas. Ann Neurol 64:644-653.
15. 2+ current in the action potentials of nociceptive sensory neurons. J Neurosci 22:10277-10290.
16. Brannagan TH III, Hays AP, Chin SS, Sander HW, Chin RL, Magda P, Green PH, Latov N (2005). Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol 62:1574-1578.
17. Bursova S, Dubovy P, Vlckova-Moravcova E, Nemec M, Klusakova I, Belobradkova J, Bednarik J (2012). Expression of growth-associated protein 43 in the skin nerve fibers of patients with type 2 diabetes mellitus. J Neurol Sci 315:60-63.
18. Castaneda-Corral G, Jimenez-Andrade JM, Bloom AP, Taylor RN, Mantyh WG, Kaczmarska MJ, Ghilardi JR, Mantyh PW (2011). The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. Neuroscience 178:196-207.
19. Catterall WA (2000). From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26:13-25.
20. Catterall WA (2012). Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol 590:2577-2589.
21. Catterall WA, Goldin AL, Waxman SG (2005). International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 57:397-409.
22. Choi JS, Boralevi F, Brissaud O, Sanchez-Martin J, Te Morsche RH, Dib-Hajj SD, Drenth JP, Waxman SG (2011). Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons. Nat Rev Neurol 7:51-55.
23. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K, Karbani G, Jafri H, Mannan J, Raashid Y, Al-Gazali L, Hamamy H, Valente EM, Gorman S, Williams R, McHale DP, Wood JN, Gribble FM, Woods CG (2006). An SCN9A channelopathy causes congenital inability to experience pain. Nature 444:894-898.
24. Cummins TR, Howe JR, Waxman SG (1998). Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 18:9607-9619.
25. Cummins TR, Dib-Hajj SD, Black JA, Akopian AN, Wood JN, Waxman SG (1999). A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci 19:RC43.
26. Cummins TR, Rush AM, Estacion M, Dib-Hajj SD, Waxman SG (2009). Voltage-clamp and current-clamp recordings from mammalian DRG neurons. Nat Protoc 4:1103-1112.
27. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, Broglio L, Granieri E, Lauria G (2008). The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131:1912-1925.
28. Dib-Hajj SD, Waxman SG (2010). Isoform-specific and pan-channel partners regulate trafficking and plasma membrane stability; and alter sodium channel gating properties. Neurosci Lett 486:84-91.
29. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG (2010). Sodium channels in normal and pathological pain. Annu Rev Neurosci 33:325-347.
30. Djouhri L, Fang X, Okuse K, Wood JN, Berry CM, Lawson SN (2003a). The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol 550:739-752.
31. Djouhri L, Newton R, Levinson SR, Berry CM, Carruthers B, Lawson SN (2003b). Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein. J Physiol 546:565-576.
32. England JD, Asbury AK (2004). Peripheral neuropathy. Lancet 363:2151-2161.
33. Estacion M, Harty TP, Choi JS, Tyrrell L, Dib-Hajj SD, Waxman SG (2009). A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann Neurol 66:862-866.
34. Estacion M, Han C, Choi JS, Hoeijmakers JG, Lauria G, Drenth JP, Gerrits MM, Dib-Hajj SD, Faber CG, Merkies IS, Waxman SG (2011). Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. Mol Pain 7:92.
35. V1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 71:26-39.
36. Faber CG, Lauria G, Merkies IS, Cheng X, Han C, Ahn HS, Persson AK, Hoeijmakers JG, Gerrits MM, Pierro T, Lombardi R, Kapetis D, Dib-Hajj SD, Waxman SG (2012b). Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A 109:19444-19449.
37. Fang X, Djouhri L, Black JA, Dib-Hajj SD, Waxman SG, Lawson SN (2002). The presence and role of the tetrodotoxin-resistant sodium channel Na(v)1.9 (NaN) in nociceptive primary afferent neurons. J Neurosci 22:7425-7433.
38. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman J, Klugbauer N, Wood JN, Gardiner RM, Rees M (2006). SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52:767-774.
39. Gerrits MM, Faber CG, Hoeijmakers JGJ, Merckx DML, Meekels LKM, Smeets HJM, Dib-Hajj SD, Waxman SG, Merkies ISJ (2013). Gain of function NaV1.7 mutations in patients with small fiber neuropathy. J Peripher Nerv Syst 18(Suppl 2):S40.
40. Goldberg YP, MacFarlane J, MacDonald ML, Thompson J, Dube MP, Mattice M, Fraser R, Young C, Hossain S, Pape T, Payne B, Radomski C, Donaldson G, Ives E, Cox J, Younghusband HB, Green R, Duff A, Boltshauser E, Grinspan GA, Dimon JH, Sibley BG, Andria G, Toscano E, Kerdraon J, Bowsher D, Pimstone SN, Samuels ME, Sherrington R, Hayden MR (2007). Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 71:311-319.
41. Gondim FA, Brannagan TH III, Sander HW, Chin RL, Latov N (2005). Peripheral neuropathy in patients with inflammatory bowel disease. Brain 128:867-879.
42. Gorson KC, Ropper AH (1995). Idiopathic distal small fiber neuropathy. Acta Neurol Scand 92:376-382.
43. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L (2004). Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 27:1591-1597.
44. Han C, Hoeijmakers JG, Ahn HS, Zhao P, Shah P, Lauria G, Gerrits MM, Te Morsche RH, Dib-Hajj SD, Drenth JP, Faber CG, Merkies IS, Waxman SG (2012a). Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability. Neurology 78:1635-1643.
45. Han C, Hoeijmakers JG, Liu S, Gerrits MM, Te Morsche RH, Lauria G, Dib-Hajj SD, Drenth JP, Faber CG, Merkies IS, Waxman SG (2012b). Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy. Brain 135:2613-2628.
46. Han C, Vasylyev D, Macala LJ, Gerrits MM, Hoeijmakers JG, Bekelaar KJ, Dib-Hajj SD, Faber CG, Merkies IS, Waxman SG (2014). The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability. J Neurol Neurosurg Psychiatry 85:499-505.
47. Hayden R, Grossman M (1959). Rectal, ocular, and submaxillary pain; a familial autonomic disorder related to proctalgia fugaz: report of a family. AMA J Dis Child 97:479-482.
48. Herzog RI, Cummins TR, Waxman SG (2001). Persistent TTX-resistant Na+ current affects resting potential and response to depolarization in simulated spinal sensory neurons. J Neurophysiol 86:1351-1364.
49. Herzog RI, Cummins TR, Ghassemi F, Dib-Hajj SD, Waxman SG (2003). Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons. J Physiol 551:741-750.
50. Hill EL, Elde R (1991). Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell Tissue Res 264:469-480.
51. Hodgkin AL, Huxley AF (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 117:500-544.
52. Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG (2012a). Small-fibre neuropathies-advances in diagnosis, pathophysiology and management. Nat Rev Neurol 8:369-379.
53. Hoeijmakers JG, Han C, Merkies IS, Macala LJ, Lauria G, Gerrits MM, Dib-Hajj SD, Faber CG, Waxman SG (2012b). Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation. Brain 135:345-358.
54. Hoeijmakers JGJ, Faber CG, Lauria G, Merkies ISJ, Cheng X, Han C, Ahn H-S, Persson A-K, Gerrits MM, Pierro T, Lombardi R, Kapetis D, Dib-Hajj SD, Waxman SG (2013). Gain-of-function NaV1.8 mutations in painful neuropathy. J Peripher Nerv Syst 18(Suppl 2):S47.
55. Hoitsma E, Marziniak M, Faber CG, Reulen JP, Sommer C, De Baets M, Drent M (2002). Small fibre neuropathy in sarcoidosis. Lancet 359:2085-2086.
56. Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC (1998). Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 44:47-59.
57. Holliday KL, Thomson W, Neogi T, Felson DT, Wang K, Wu FC, Huhtaniemi IT, Bartfai G, Casanueva F, Forti G, Kula K, Punab M, Vanderschueren D, Macfarlane GJ, Horan MA, Ollier W, Payton A, Pendleton N, McBeth J (2012). The non-synonymous SNP, R1150W, in SCN9A is not associated with chronic widespread pain susceptibility. Mol Pain 8:72.
58. Houlden H, Blake J, Reilly MM (2004). Hereditary sensory neuropathies. Curr Opin Neurol 17:569-577.
59. Huang J, Yang Y, Zhao P, Gerrits MM, Hoeijmakers JG, Bekelaar K, Merkies IS, Faber CG, Dib-Hajj SD, Waxman SG (2013). Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons. J Neurosci 33:14087-14097.
60. Jimenez-Andrade JM, Mantyh WG, Bloom AP, Xu H, Ferng AS, Dussor G, Vanderah TW, Mantyh PW (2010). A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: therapeutic opportunity for treating skeletal pain. Bone 46:306-313.
61. Joint Task Force of the EFNS and the PNS (2010). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 15:79-92.
62. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F (1995). Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBOJ 14:1084-1090.
63. Lacomis D (2002). Small-fiber neuropathy. Muscle Nerve 26:173-188.
64. Lacomis D, Giuliani MJ, Steen V, Powell HC (1997). Small fiber neuropathy and vasculitis. Arthritis Rheum 40:1173-1177.
65. Lai J, Porreca F, Hunter JC, Gold MS (2004). Voltage-gated sodium channels and hyperalgesia. Annu Rev Pharmacol Toxicol 44:371-397.
66. Langer LO, Garrett RT (1980). Acromesomelic dysplasia. Radiology 137:349-355.
67. Lauria G (2005). Small fibre neuropathies. Curr Opin Neurol 18:591-597.
68. Lauria G (2013). Kick off meeting of the PROPANE STUDY. J Peripher Nerv Syst 18:273-274.
69. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, Smith AG, Hsieh ST, Mellgren SI, Umapathi T, Ziegler D, Faber CG, Merkies IS (2010a). Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 15:202-207.
70. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, Nolano M, Merkies IS, Polydefkis M, Smith AG, Sommer C, Valls-Sole J (2010b). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 17(903-912):e944-e949.
71. Lawson SN (2002). Phenotype and function of somatic primary afferent nociceptive neurones with C-, Adelta- or Aalpha/beta-fibres. Exp Physiol 87:239-244.
72. Lee Y, Lee CH, Oh U (2005). Painful channels in sensory neurons. Mol Cells 20:315-324.
73. Leipold E, Liebmann L, Korenke GC, Heinrich T, Giesselmann S, Baets J, Ebbinghaus M, Goral RO, Stodberg T, Hennings JC, Bergmann M, Altmuller J, Thiele H, Wetzel A, Nurnberg P, Timmerman V, De Jonghe P, Blum R, Schaible HG, Weis J, Heinemann SH, Hubner CA, Kurth I (2013). A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet 45:1399-1404.
74. Martyn CN, Hughes RA (1997). Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 62:310-318.
75. McCleskey EW, Gold MS (1999). Ion channels of nociception. Annu Rev Physiol 61:835-856.
76. McManis PG, Windebank AJ, Kiziltan M (1994). Neuropathy associated with hyperlipidemia. Neurology 44:2185-2186.
77. Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M (2004). The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 17:309-318.
78. Molleman A (2003). Patch clamping: an introductory guide to patch clamp electrophysiology. John Wiley & Sons Ltd, Chichester.
79. Ostman JA, Nassar MA, Wood JN, Baker MD (2008). GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9. J Physiol 586:1077-1087.
80. Pareyson D (2003). Diagnosis of hereditary neuropathies in adult patients. J Neurol 250:148-160.
81. Persson A-K, Liu S, Faber CG, Merkies ISJ, Black JA, Waxman SG (2013). Neuropathy-associated Nav1.7 variant I228M impairs integrity of DRG neuron axons. Ann Neurol 73:140-145.
82. Peters MJ, Bakkers M, Merkies IS, Hoeijmakers JG, van Raak EP, Faber CG (2013). Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology 81:1356-1360.
83. Plante-Bordeneuve V, Said G (2011). Familial amyloid polyneuropathy. Lancet Neurol 10:1086-1097.
84. Polydefkis M, Yiannoutsos CT, Cohen BA, Hollander H, Schifitto G, Clifford DB, Simpson DM, Katzenstein D, Shriver S, Hauer P, Brown A, Haidich AB, Moo L, McArthur JC (2002). Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58:115-119.
85. Reimann F, Cox JJ, Belfer I, Diatchenko L, Zaykin DV, McHale DP, Drenth JP, Dai F, Wheeler J, Sanders F, Wood L, Wu TX, Karppinen J, Nikolajsen L, Mannikko M, Max MB, Kiselycznyk C, Poddar M, Te Morsche RH, Smith S, Gibson D, Kelempisioti A, Maixner W, Gribble FM, Woods CG (2010). Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A 107:5148-5153.
86. Renganathan M, Cummins TR, Waxman SG (2001). Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol 86:629-640.
87. Rush AM, Dib-Hajj SD, Liu S, Cummins TR, Black JA, Waxman SG (2006). A single sodium channel mutation produces hyperor hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A 103:8245-8250.
88. Rush AM, Cummins TR, Waxman SG (2007). Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J Physiol 579:1-14.
89. Sangameswaran L, Delgado SG, Fish LM, Koch BD, Jakeman LB, Stewart GR, Sze P, Hunter JC, Eglen RM, Herman RC (1996). Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem 271:5953-5956.
90. Scott LJ, Griffin JW, Luciano C, Barton NW, Banerjee T, Crawford T, McArthur JC, Tournay A, Schiffmann R (1999). Quantitative analysis of epidermal innervation in Fabry disease. Neurology 52:1249-1254.
91. Sherrington CS (1906). Observations on the scratch-reflex in the spinal dog. J Physiol 34:1-50.
92. Shields SD, Ahn HS, Yang Y, Han C, Seal RP, Wood JN, Waxman SG, Dib-Hajj SD (2012). Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system. Pain 153:2017-2030.
93. Smith AG, Ramachandran P, Tripp S, Singleton JR (2001). Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57:1701-1704.
94. Stewart JD, Low PA, Fealey RD (1992). Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve 15:661-665.
95. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M (2003). The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60:108-111.
96. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P (2010). Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285-2293.
97. Uceyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A, Casanova-Molla J, Reiners K, Sommer C (2013). Small fibre pathology in patients with fibromyalgia syndrome. Brain 136:1857-1867.
98. Valdes AM, Arden NK, Vaughn FL, Doherty SA, Leaverton PE, Zhang W, Muir KR, Rampersaud E, Dennison EM, Edwards MH, Jameson KA, Javaid MK, Spector TD, Cooper C, Maciewicz RA, Doherty M (2011). Role of the Nav1.7 R1150W amino acid change in susceptibility to symptomatic knee osteoarthritis and multiple regional pain. Arthritis Care Res (Hoboken) 63:440-444.
99. Vargas-Alarcon G, Alvarez-Leon E, Fragoso JM, Vargas A, Martinez A, Vallejo M, Martinez-Lavin M (2012). A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord 13:23.
100. Vargesson N (2009). Thalidomide-induced limb defects: resolving a 50-year-old puzzle. Bioessays 31:1327-1336.
101. Wallis Y, Payne S, McAnulty C, Bodmer D, Sistermans E, Robertson K, Moore D, Abbs S, Deans Z, Devereau A (2013). Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics. Association for Clinical Genetic Science (ACGS), Birmingham, pp 1-16.
102. Waxman SG (2000). The neuron as a dynamic electrogenic machine: modulation of sodium-channel expression as a basis for functional plasticity in neurons. Philos Trans R Soc Lond B Biol Sci 355:199-213.
103. Waxman SG (2006). Neurobiology: a channel sets the gain on pain. Nature 444:831-832.
104. Waxman SG, Kocsis JD, Black JA (1994). Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 72:466-470.
105. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Adel G, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-172.
106. Yang Y, Wang Y, Li S, Xu Z, Li H, Ma L, Fan J, Bu D, Liu B, Fan Z, Wu G, Jin J, Ding B, Zhu X, Shen Y (2004). Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 41:171-174.
107. Yu FH, Catterall WA (2003). Overview of the voltage-gated sodium channel family. Genome Biol 4:207.
108. Zambelis T, Karandreas N, Tzavellas E, Kokotis P, Liappas J (2005). Large and small fiber neuropathy in chronic alcohol-dependent subjects. J Peripher Nerv Syst 10:375-381.
109. Zhang XY, Wen J, Yang W, Wang C, Gao L, Zheng LH, Wang T, Ran K, Li Y, Li X, Xu M, Luo J, Feng S, Ma X, Ma H, Chai Z, Zhou Z, Yao J, Zhang X, Liu JY (2013). Gain-of-function mutations in SCN11A cause familial episodic pain. Am J Hum Genet 93:957-966.